Rorze Lifescience to absorb Genostaff in internal merger, Genostaff dissolved Sept. 1, 2026

• Rorze will merge two life science subsidiaries, with Rorze Lifescience absorbing Genostaff in an intra-group reorganization.
• Genostaff will be dissolved; the absorption-type merger takes effect Sept. 1, 2026.
• The group aims to consolidate management resources, lift efficiency, strengthen competitiveness in life science.
• Impact on consolidated results expected to be immaterial.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rorze Corporation published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.